{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:03:01Z","timestamp":1791644581142,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2307601"],"award-info":[{"award-number":["2023YFC2307601"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.cmi.2025.09.009","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T23:28:07Z","timestamp":1758065287000},"page":"128-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial"],"prefix":"10.1016","volume":"32","author":[{"given":"Shenyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huakun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.09.009_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/1346-8138.16666","article-title":"Recent topics in the management of herpes zoster","volume":"50","author":"Asada","year":"2023","journal-title":"J Dermatol"},{"key":"10.1016\/j.cmi.2025.09.009_bib2","doi-asserted-by":"crossref","first-page":"ITC19","DOI":"10.7326\/L18-0558","article-title":"Herpes zoster","volume":"169","author":"Schmader","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2025.09.009_bib3","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1093\/cid\/ciac549","article-title":"Increased stroke risk following herpes zoster infection and protection with zoster vaccine","volume":"76","author":"Parameswaran","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.09.009_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2228169","article-title":"The incidence of herpes zoster in China: a meta-analysis and evidence quality assessment","volume":"19","author":"Zhang","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2025.09.009_bib5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jiph.2023.05.016","article-title":"The necessity for popularizing varicella-zoster virus vaccine programs worldwide: an age-period-cohort analysis for the Global Burden of Disease study 2019","volume":"16","author":"Zhang","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.cmi.2025.09.009_bib6","article-title":"Disease burden due to herpes zoster among population aged \u226550 years old in China: a community based retrospective survey","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"suppl_2","key":"10.1016\/j.cmi.2025.09.009_bib7","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/infdis\/jiy418","article-title":"Point-counterpoint: the hope-simpson hypothesis and its implications regarding an effect of routine varicella vaccination on herpes zoster incidence","volume":"218","author":"Harpaz","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.09.009_bib8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1080\/21645515.2015.1016672","article-title":"Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China","volume":"11","author":"Zhu","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.cmi.2025.09.009_bib9","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1016\/j.vaccine.2019.04.014","article-title":"The comparative efficacy and safety of herpes zoster vaccines: a network meta-analysis","volume":"37","author":"McGirr","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2025.09.009_bib10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.09.009_bib11","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2025.09.009_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14760584.2021.1954910","article-title":"Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50\u201369 years","volume":"20","author":"Lu","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.cmi.2025.09.009_bib13","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/21645515.2018.1560918","article-title":"Immune responses to zoster vaccines","volume":"15","author":"Levin","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"2 Pt 1","key":"10.1016\/j.cmi.2025.09.009_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0091-6749(99)70508-7","article-title":"A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids","volume":"103","author":"Nakayama","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.cmi.2025.09.009_bib15","first-page":"631","article-title":"Identifying the optimal age for herpes zoster vaccination - Yichang City, Hubei Province, China, 2017-2019","volume":"4","author":"You","year":"2022","journal-title":"China CDC Wkly"},{"key":"10.1016\/j.cmi.2025.09.009_bib16","unstructured":"National Medical Products Administration (NMPA). Guiding Principles for the Grading Standards of Adverse Events in Clinical Trials of Prophylactic Vaccines [in Chinese]. 2019 Dec 31. Available at: https:\/\/www.nmpa.gov.cn\/xxgk\/ggtg\/ypggtg\/ypqtggtg\/20191231111901460.html (accessed 30 September 2025)."},{"key":"10.1016\/j.cmi.2025.09.009_bib17","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/03610929808832160","article-title":"Exact power and sample size for vaccine efficacy studies","volume":"27","author":"Chan","year":"1998","journal-title":"Commun Stat Theor Methods"},{"issue":"4","key":"10.1016\/j.cmi.2025.09.009_bib18","first-page":"130","article-title":"Evaluation of efficacy and effectiveness of live attenuated zoster vaccine","volume":"55","author":"Gabutti","year":"2014","journal-title":"J Prev Med Hyg"},{"key":"10.1016\/j.cmi.2025.09.009_bib19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.puhe.2018.10.015","article-title":"Systematic review of the evidence on the epidemiology of herpes zoster: Incidence in the general population and specific subpopulations in Spain","volume":"167","author":"Mareque","year":"2019","journal-title":"Public Health"},{"key":"10.1016\/j.cmi.2025.09.009_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1370\/afm.707","article-title":"Clinical diagnosis of herpes zoster in family practice","volume":"5","author":"Opstelten","year":"2007","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.cmi.2025.09.009_bib21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.09.009_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7326\/M23-2023","article-title":"Effectiveness of recombinant zoster vaccine against herpes zoster in a real-world setting","volume":"177","author":"Zerbo","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2025.09.009_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.09.009_bib24","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"12 suppl 2","key":"10.1016\/j.cmi.2025.09.009_bib25","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiab387","article-title":"Herpes zoster vaccines","volume":"224","author":"Harbecke","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2025.09.009_bib26","first-page":"432","article-title":"et al.Epidemiological characteristics of herpes zoster in urban areas of Yichang city during 2016-2017 based on the Yichang Big data platform for health management","volume":"4","author":"Jiang","year":"2019","journal-title":"Chin J Vaccines Immunization"},{"key":"10.1016\/j.cmi.2025.09.009_bib27","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12879-018-3395-z","article-title":"Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above","volume":"18","author":"Curran","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.09.009_bib28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s40520-019-01374-5","article-title":"Vaccination for quality of life: herpes-zoster vaccines","volume":"33","author":"Lang","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.cmi.2025.09.009_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2147\/CEOR.S203920","article-title":"Patient and economic burdens of postherpetic neuralgia in China","volume":"11","author":"Yu","year":"2019","journal-title":"Clinicoecon Outcome Res"},{"key":"10.1016\/j.cmi.2025.09.009_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.vaccine.2023.12.082","article-title":"A retrospective cohort study evaluating the incidence of herpes zoster and postherpetic neuralgia after a live attenuated Oka-strain herpes zoster vaccine in a real-world setting in Japan","volume":"42","author":"Yaegashi","year":"2024","journal-title":"Vaccine"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25004598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X25004598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:28:20Z","timestamp":1772882900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X25004598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1198743X25004598"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.09.009","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of a China-developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double-blind, placebo-controlled, phase 3 clinical trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}